PHVS insider ownership: who sold, why, and what they still hold

What stands out

Four insiders sold $14.6M with no disclosed plan: Johannes Schikan ($7.0M), Peng Lu ($3.5M) and Stefan Abele ($2.0M), plus 1 more. The filings don't state a reason.Johannes Schikan: largest such sale, Sep 17, 2026 · Peng Lu: largest such sale, Sep 17, 2026 · Stefan Abele: largest such sale, Sep 15, 2026

A share of stake is shown for 0 of the 11 officers and directors who sold. 13 are left out

Left out: Berndt Modig, Johannes Schikan, Anne Lesage, David Nassif, Annick Deschoolmeester, Peng Lu, David Meeker, Wim Souverijns, Anna Nijdam, Stefan Abele, Elisabeth Bjork, Robert Glassman and Viviane Monges (share of stake is being verified).

Disclosed company stock is not an insider's whole wealth.

Who sold, and how much of their stake

Officers and directors, since March 18, 2026. Their share of stake is being verified and is not shown yet; amounts and trading plans are below.

Johannes Schikan

Director

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$9.7M27% planned 73% no plan disclosed

Peng Lu

President

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$6.9M50% planned 50% no plan disclosed

Anne Lesage

Chief Early Development

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$6.7M89% planned 11% no plan disclosed

Elisabeth Bjork

Director

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$2.3M13% planned 87% no plan disclosed

Stefan Abele

Chief Technical Ops Officer

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$2.0MNo plan disclosed

All 11 sellers

Selling by month

Officers and directors, Mar 2026 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planTo cover taxesNo plan disclosedOne dollar scale for every month; the tallest bar is labeled

Recent activity

Past 30 days, Sep 17, 2026 to Oct 16, 2026

Oct 12, 2026Peng Lu had 117 shares ($4K) withheld by the company for taxes (not a market sale).

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Peng Lu President	117	$31.10	n/a	n/a	Oct 12, 2026	Oct 13, 2026

Oct 11, 2026Peng Lu had 109 shares ($3K) withheld by the company for taxes (not a market sale).

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Peng Lu President	109	$31.10	n/a	n/a	Oct 11, 2026	Oct 13, 2026

Sep 23, 2026Viviane Monges sold 12K shares ($396K) with no plan disclosed. 12K shares came in from vesting or option exercises the same day, so the holding rose by 0 net.

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Viviane Monges Director	11,969	$33.05	n/a	n/a	Sep 23, 2026	Sep 25, 2026

Sep 22, 2026Johannes Schikan sold 800 shares ($29K) with no plan disclosed. 800 shares came in from vesting or option exercises the same day, so the holding rose by 0 net.

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Johannes Schikan Director	800	$36.19	n/a	n/a	Sep 22, 2026	Sep 24, 2026

Sep 21, 2026David Nassif sold 6K shares ($219K) with no plan disclosed.

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
David Nassif CFO / CLO	6,000	$36.47	n/a	n/a	Sep 21, 2026	Sep 23, 2026

Show all 8 events

Sep 21, 2026David Nassif gave away 500 shares as a gift.

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
David Nassif CFO / CLO	500	n/a	n/a	n/a	Sep 21, 2026	Sep 23, 2026

Sep 17, 20264 insiders sold 373K shares ($13.3M) with no plan disclosed. 153K shares came in from vesting or option exercises the same day, so their combined holdings fell by 220K net.

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Johannes Schikan Director	200,000	$35.00	n/a	n/a	Sep 17, 2026	Sep 21, 2026
Peng Lu President	100,000	$35.00	n/a	n/a	Sep 17, 2026	Sep 21, 2026
Elisabeth Bjork Director	52,500	$37.89	n/a	n/a	Sep 17, 2026	Sep 21, 2026
Anne Lesage Chief Early Development	20,000	$38.27	n/a	n/a	Sep 17, 2026	Sep 21, 2026

Sep 17, 2026Robert Glassman sold 14K shares ($559K) under a disclosed trading plan. 14K shares came in from vesting or option exercises the same day, so the holding rose by 0 net.

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Robert Glassman Director	14,493	$38.56	n/a	n/a	Sep 17, 2026	Sep 21, 2026

"% of total stake" is the shares in an event against all the vested shares the person held that day, across every share class and holding entity, after that day's vesting. "n/a" means the person's holdings are not confirmed, or the row is a purchase. "Holdings record incomplete" means more shares were sold than the filings show the person held that day, so a percentage would be wrong.

Common questions

Is the Pharvaris N.V. CEO selling stock?

Yes. Berndt Modig sold 37K shares ($1.1M) since March 18, 2026, all of it under a trading plan disclosed in the filings.

Why are Pharvaris N.V. insiders selling?

Filings rarely give a reason, and we don't guess at one. What they show is how the sales were made: 48% of sales by value ran under 10b5-1 trading plans disclosed in the filings, 2% were to cover taxes and 50% had no disclosed plan. A trading plan schedules sales in advance.

Are any Pharvaris N.V. insiders buying?

No. Officers and directors reported no purchases since March 18, 2026.

The evidence

Who sold11 officers and directors: amount, % of holdings, trading plan

Who sold	Amount	% of holdings	Trading plan
Johannes Schikan Director	$9.7M 281K shares	Not confirmed share of stake is being verified. Why	27% under a disclosed plan 73% no plan disclosed
Peng Lu President	$6.9M 200K shares	Not confirmed share of stake is being verified. Why	50% under a disclosed plan 50% no plan disclosed
Anne Lesage Chief Early Development	$6.7M 194K shares	Not confirmed share of stake is being verified. Why	89% under a disclosed plan 11% no plan disclosed
Elisabeth Bjork Director	$2.3M 63K shares	Not confirmed share of stake is being verified. Why	13% under a disclosed plan 87% no plan disclosed
Stefan Abele Chief Technical Ops Officer	$2.0M 55K shares	Not confirmed share of stake is being verified. Why	No plan disclosed
Robert Glassman Director	$1.5M 41K shares	Not confirmed share of stake is being verified. Why	80% under a disclosed plan 20% no plan disclosed
Wim Souverijns Chief Commercial Officer	$1.3M 36K shares	Not confirmed share of stake is being verified. Why	Disclosed plan
Berndt Modig Chief Executive Officer, Director	$1.1M 37K shares	Not confirmed share of stake is being verified. Why	Disclosed plan
Viviane Monges Director	$688K 22K shares	Not confirmed share of stake is being verified. Why	43% to cover taxes 57% no plan disclosed
David Nassif CFO / CLO	$522K 16K shares	Not confirmed share of stake is being verified. Why	58% to cover taxes 42% no plan disclosed
Anna Nijdam Principal Accounting Officer	$307K 10K shares	Not confirmed share of stake is being verified. Why	No plan disclosed

The full ownership picture0 of 13 officers and directors confirmed

Vested shares across all share classes, held directly and through trusts, LLCs and family members, as reported on SEC Forms 3, 4 and 5. Unvested awards and options are never counted as owned shares.

Insider

Held Mar 17, 2026

Sold

Held Oct 16, 2026

Still held

Berndt Modig

Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Berndt Modig are complete.

Chief Executive Officer, Director

n/a

−37K

n/a

Vesting, gifts, unvested awards and holding lines for Berndt Modig

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Berndt Modig are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
210,000	$28.00	Mar 3, 2036	$1.1M
180,000	$16.05	Mar 12, 2035	$3.1M
150,000	$22.31	Apr 11, 2034	$1.6M
170,000	$8.05	Apr 6, 2033	$4.2M
140,000	$18.14	Apr 1, 2032	$2.1M
250,000	$20.00	Feb 5, 2031	$3.3M

Estimate: options held × ($33.05 − strike price), using the most recent insider trade price on Form 4 (Sep 23, 2026), not a market close.

Johannes Schikan

Director

n/a

−281K

n/a

Vesting, gifts, unvested awards and holding lines for Johannes Schikan

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Johannes Schikan are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
16,500	$28.00	Mar 3, 2036	$83K
15,000	$16.05	Mar 12, 2035	$255K
14,000	$22.31	Apr 11, 2034	$150K
21,000	$8.05	Apr 6, 2033	$525K
17,500	$18.14	Apr 1, 2032	$261K
34,200	$20.00	Feb 5, 2031	$446K

Estimate: options held × ($33.05 − strike price), using the most recent insider trade price on Form 4 (Sep 23, 2026), not a market close.

Anne Lesage

Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. See the filing Sales and other transactions for Anne Lesage are complete.

Chief Early Development

n/a

−194K

n/a

Vesting, gifts, unvested awards and holding lines for Anne Lesage

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Anne Lesage are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
60,000	$28.00	Mar 3, 2036	$303K
60,000	$16.05	Apr 12, 2035	$1.0M
50,000	$22.31	Apr 11, 2034	$537K
82,000	$8.05	Apr 6, 2033	$2.0M
65,000	$18.14	Apr 1, 2032	$969K
120,000	$20.00	Feb 5, 2031	$1.6M
15,872	$2.59	Jan 1, 2030	$483K
113,000	$8.05	Feb 5, 2031	$2.8M
9,072	$2.59	Jan 1, 2030	$276K
45,000	$8.05	Apr 6, 2033	$1.1M
7,072	$2.59	Jan 1, 2030	$215K
15,000	$8.05	Apr 6, 2033	$375K

Estimate: options held × ($33.05 − strike price), using the most recent insider trade price on Form 4 (Sep 23, 2026), not a market close.

David Nassif

CFO / CLO

n/a

−16K

n/a

Vesting, gifts, unvested awards and holding lines for David Nassif

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for David Nassif are complete; balances and unit counts will be added when the check is finished.

−500gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
60,000	$28.00	Mar 3, 2036	$303K
60,000	$16.05	Apr 12, 2035	$1.0M
75,000	$15.94	Aug 1, 2034	$1.3M
230,000	$20.15	Apr 15, 2034	$3.0M

Estimate: options held × ($33.05 − strike price), using the most recent insider trade price on Form 4 (Sep 23, 2026), not a market close.

Annick Deschoolmeester

Chief Human Resources Officer

n/a

Vesting, gifts, unvested awards and holding lines for Annick Deschoolmeester

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Annick Deschoolmeester are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
60,000	$28.00	Mar 3, 2036	$303K
60,000	$16.05	Apr 12, 2035	$1.0M
45,000	$22.31	Apr 11, 2034	$483K
70,000	$8.05	Apr 6, 2033	$1.7M

Estimate: options held × ($33.05 − strike price), using the most recent insider trade price on Form 4 (Sep 23, 2026), not a market close.

Peng Lu

Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Peng Lu are complete.

President

n/a

−200K

n/a

Vesting, gifts, unvested awards and holding lines for Peng Lu

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Peng Lu are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

−1.6Kwithheld by the company for taxes

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
70,000	$28.00	Mar 3, 2036	$353K
67,500	$16.05	Mar 12, 2035	$1.1M
65,000	$22.31	Apr 11, 2034	$698K
73,118	$8.05	Apr 6, 2033	$1.8M
6,882	$8.05	Apr 6, 2033	$172K
57,669	$18.14	Apr 1, 2032	$860K
7,301	$18.14	Apr 1, 2032	$109K
14,000	$20.00	Feb 5, 2031	$183K
65,000	$20.00	Feb 5, 2031	$848K
245,308	$2.59	Feb 3, 2030	$7.5M
106,207	$2.59	Feb 3, 2030	$3.2M
175,308	$2.59	Feb 3, 2030	$5.3M
43,308	$2.59	Feb 3, 2030	$1.3M

Estimate: options held × ($33.05 − strike price), using the most recent insider trade price on Form 4 (Sep 23, 2026), not a market close.

David Meeker

Director

n/a

Vesting, gifts, unvested awards and holding lines for David Meeker

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for David Meeker are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
16,500	$28.00	Mar 3, 2036	$83K
15,000	$16.05	Mar 12, 2035	$255K
14,000	$22.31	Apr 11, 2034	$150K
21,000	$8.05	Apr 6, 2033	$525K
17,500	$18.14	Apr 1, 2032	$261K
80,000	$7.89	Jan 1, 2031	$2.0M

Estimate: options held × ($33.05 − strike price), using the most recent insider trade price on Form 4 (Sep 23, 2026), not a market close.

Wim Souverijns

Chief Commercial Officer

n/a

−36K

n/a

Vesting, gifts, unvested awards and holding lines for Wim Souverijns

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Wim Souverijns are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
55,000	$28.00	Mar 3, 2036	$278K
67,500	$16.05	Apr 12, 2035	$1.1M
45,000	$22.31	Apr 11, 2034	$483K
75,000	$8.05	Apr 6, 2033	$1.9M
65,000	$18.14	Apr 1, 2032	$969K
95,000	$17.43	Jul 1, 2031	$1.5M

Estimate: options held × ($33.05 − strike price), using the most recent insider trade price on Form 4 (Sep 23, 2026), not a market close.

Anna Nijdam

Principal Accounting Officer

n/a

−10K

n/a

Vesting, gifts, unvested awards and holding lines for Anna Nijdam

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Anna Nijdam are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

−2.9Kwithheld by the company for taxes

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
22,670	$20.00	Feb 5, 2031	$296K

Estimate: options held × ($33.05 − strike price), using the most recent insider trade price on Form 4 (Sep 23, 2026), not a market close.

Stefan Abele

Chief Technical Ops Officer

n/a

−55K

n/a

Vesting, gifts, unvested awards and holding lines for Stefan Abele

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Stefan Abele are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
60,000	$28.00	Mar 3, 2036	$303K
60,000	$16.05	Apr 12, 2035	$1.0M
40,000	$22.31	Apr 11, 2034	$429K
44,500	$16.40	Nov 15, 2033	$741K

Estimate: options held × ($33.05 − strike price), using the most recent insider trade price on Form 4 (Sep 23, 2026), not a market close.

Elisabeth Bjork

Director

n/a

−63K

n/a

Vesting, gifts, unvested awards and holding lines for Elisabeth Bjork

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Elisabeth Bjork are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
16,500	$28.00	Mar 3, 2036	$83K
15,000	$16.05	Mar 12, 2035	$255K
14,000	$22.31	Apr 11, 2034	$150K
11,000	$8.05	Apr 6, 2033	$275K

Estimate: options held × ($33.05 − strike price), using the most recent insider trade price on Form 4 (Sep 23, 2026), not a market close.

Robert Glassman

Director

n/a

−41K

n/a

Vesting, gifts, unvested awards and holding lines for Robert Glassman

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Robert Glassman are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
16,500	$28.00	Mar 3, 2036	$83K
15,000	$16.05	Mar 12, 2035	$255K
21,000	$8.05	Apr 6, 2033	$525K
23,300	$7.89	Jan 1, 2031	$586K

Estimate: options held × ($33.05 − strike price), using the most recent insider trade price on Form 4 (Sep 23, 2026), not a market close.

Viviane Monges

Director

n/a

−22K

n/a

Vesting, gifts, unvested awards and holding lines for Viviane Monges

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Viviane Monges are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
16,500	$28.00	Mar 3, 2036	$83K
15,000	$16.05	Mar 12, 2035	$255K
14,000	$22.31	Apr 11, 2034	$150K
9,031	$8.05	Apr 6, 2033	$226K
17,500	$18.14	Apr 1, 2032	$261K
35,000	$17.43	Jul 1, 2031	$547K

Estimate: options held × ($33.05 − strike price), using the most recent insider trade price on Form 4 (Sep 23, 2026), not a market close.

Holdings and share of stake for Pharvaris N.V. are being verified, so no balances, unit counts or percentages are shown. Sales, proceeds, plan and tax status, titles and dates come straight from individual filings.

What explains the selling$33.0M of sales by plan status, purpose, seller and month

Officer and director open-market sales: $33.0M across 954,189 shares. Plan status and stated purpose are separate questions, and a sale can have both.

By plan status

Disclosed plan · $15.9M · 48%

52%

The lighter segment is sales with no plan disclosed in the filing ($17.1M), including tax-related sales outside a plan.

No plan disclosed · $16.5M

Sales with no 10b5-1 plan and no tax reference in the filing. $7.0M of it is Johannes Schikan. No plan disclosed is a statement about the filing, not about why the sale happened. Largest such sale: Johannes Schikan, Sep 17, 2026

Taxes

$596K of sales (1.8%) cite tax obligations in their footnotes. Separately, 4,461 shares ($133K) were withheld by the company for taxes, which isn't a market sale. Example: Viviane Monges, May 21, 2026

Charitable gifts · 500 shares

Gifts the filings describe as charitable. Gifts are not sales and are not included in the sale totals.

Seller	Shares sold	Proceeds	Under a disclosed plan	Share of total	Sales dates
Johannes Schikan Director	281K	$9.7M	27%	29%	Apr 22, 2026 to Sep 22, 2026
Peng Lu President	200K	$6.9M	50%	21%	Apr 22, 2026 to Sep 17, 2026
Anne Lesage Chief Early Development	194K	$6.7M	89%	20%	Apr 22, 2026 to Sep 17, 2026
Elisabeth Bjork Director	63K	$2.3M	13%	7%	May 20, 2026 to Sep 17, 2026
Stefan Abele Chief Technical Ops Officer	55K	$2.0M	0%	6%	May 15, 2026 to Sep 15, 2026
Robert Glassman Director	41K	$1.5M	80%	5%	May 15, 2026 to Sep 17, 2026
Wim Souverijns Chief Commercial Officer	36K	$1.3M	100%	4%	May 15, 2026 to Sep 15, 2026
Berndt Modig Chief Executive Officer, Director	37K	$1.1M	100%	3%	Apr 9, 2026 to Sep 14, 2026
Viviane Monges Director	22K	$688K	0%	2%	May 21, 2026 to Sep 23, 2026
David Nassif CFO / CLO	16K	$522K	0%	2%	May 21, 2026 to Sep 21, 2026
Anna Nijdam Principal Accounting Officer	10K	$307K	0%	0.9%	May 21, 2026 to Jun 4, 2026

Sales by month

Month	Sale proceeds	Disclosed plan	To cover taxes	No plan disclosed
Mar 2026	$0	$0	$0	$0
Apr 2026	$4.6M	$4.6M	$0	$0
May 2026	$2.5M	$1.1M	$596K	$784K
Jun 2026	$5.5M	$5.4M	$0	$82K
Jul 2026	$80K	$80K	$0	$0
Aug 2026	$80K	$80K	$0	$0
Sep 2026	$20.3M	$4.7M	$0	$15.7M
Oct 2026	$0	$0	$0	$0

Known gaps and uncertainty13 officers and directors not confirmed

Holdings and share of stake are being verified. Balances, unit counts and every share-of-stake figure for Pharvaris N.V. are held back until that check is finished. Sales, proceeds, plan and tax status, titles and dates come straight from individual filings and are complete.

External context: we only cite outside events when a documented connection exists. None is shown for this period.

Sources and methodology70 filings on record, 70 filed since March 18, 2026, and how we read them

All 70 Forms 3, 4 and 5 on record for Pharvaris N.V. (SEC CIK 1830487), filed from Mar 18, 2026 to Oct 13, 2026; 70 of them were filed in the 12 months this page covers, retrieved from SEC EDGAR on Oct 16, 2026. Prices are the ones reported in each filing, often weighted averages.

Holdings. Each holding line (a share class plus an owner, such as a trust or LLC) carries its last reported balance forward. Entities first reported during the period start at zero, so transfers between an insider's own trusts don't count as selling. Lines not reported for three years or more are listed separately and left out of totals.

Sales. A sale counts as under a 10b5-1 plan if its footnote cites one or the filing's Rule 10b5-1 box is checked, and as tax-related if its footnote cites tax obligations or sell-to-cover. Shares withheld by the company for taxes are listed separately. Sales with neither attribute are labeled "no plan disclosed".

Full methodology

Spotted something wrong on this page? Report an error. We check every report against the SEC filing and list what we fix in the corrections log.

Pharvaris N.V. insiders sold $33.0M since March 18, 2026. How much of their stake is that?

What stands out

Who sold, and how much of their stake

Selling by month

Recent activity

Common questions

Is the Pharvaris N.V. CEO selling stock?

Why are Pharvaris N.V. insiders selling?

Are any Pharvaris N.V. insiders buying?

The evidence

No plan disclosed · $16.5M

Taxes

Charitable gifts · 500 shares

Sales by month